From: Impact of COVID-19 on urgent gastrointestinal surgery outcomes: increased mortality in 2020
Overall n = 2692 | 2018 n = 541 | 2019 n = 624 | 2020 n = 394 | 2021 n = 533 | 2022 n = 600 | P | |
---|---|---|---|---|---|---|---|
Demographic data | |||||||
Age, years, median [IQR] | 47.9[31.6–67.6] | 46.2[30.5–65.5] | 47.5[31.4–67] | 47.7[31.4–69.2] | 52.8[33.3–70.5] | 46.7[31.3–67] | 0.060§ |
Charlson score, median [IQR] | 2[0–5] | 2[0–5] | 1[0–4] | 2[0–5] | 2[0–5] | 1[0–5] | 0.258§ |
Male gender, n (%) | 1461(54.3%) | 301(55.6%) | 361(57.9%) | 201(51%) | 286(53.7%) | 312(52%) | 0.151° |
SARS-CoV-2 positive, n (%) | 84(3.1%) | 15(3.8%) | 37(6.9%) | 32(5.3%) | 0.000° | ||
Post-operative complications | |||||||
ICU admission, n (%) | 331(12.3%) | 69(12.8%) | 75(12%) | 60(15.2%) | 66(12.4%) | 61(10.2%) | 0.203° |
ICU LOS, days, median [IQR] | 0.8[0.5–2.5] | 0.8[0.5–3.7] | 0.9[0.6–3.6] | 0.7[0.5–1] | 0.8[0.5–1.1] | 0.8[0.6–2.7] | 0.770§ |
Acute kidney failure, n (%) | 180(6.7%) | 38(7%) | 39(6.2%) | 28(7.1%) | 39(7.3%) | 36(6%) | 0.875° |
Acute respiratory failure, n (%) | 135(5%) | 29(5.4%) | 36(5.8%) | 22(5.6%) | 27(5.1%) | 21(3.5%) | 0.359° |
Bacterial pneumonia, n (%) | 60(2.2%) | 15(2.8%) | 15(2.4%) | 8(2%) | 11(2.1%) | 11(1.8%) | 0.864° |
Aspiration pneumonia, n (%) | 67(2.5%) | 12(2.2%) | 13(2.1%) | 13(3.3%) | 14(2.6%) | 15(2.5%) | 0.781° |
Acute liver failure, n (%) | 22(0.8%) | 5(0.9%) | 2(0.3%) | 5(1.3%) | 5(0.9%) | 5(0.8%) | 0.458* |
Pulmonary embolism, n (%) | 24(0.9%) | 3(0.6%) | 4(0.6%) | 8(2%) | 4(0.8%) | 5(0.8%) | 0.207* |
LOS, days, median [IQR] | 3.9[1.7–9.6] | 3.8[1.8–9.8] | 4[1.8–9.8] | 3.7[1.6–10.1] | 4.2[1.7–9.6] | 3.8[1.6–8.6] | 0.269§ |
Subsequent surgery, n (%) | 133(4.9%) | 19(3.5%) | 25(4%) | 19(4.8%) | 28(5.3%) | 42(7%) | 0.063° |
Subsequent hospitalization, n (%) | 419(15.6%) | 78(14.4%) | 84(13.5%) | 52(13.2%) | 92(17.3%) | 113(18.8%) | 0.039° |
Death at day 90, n (%) | 157(5.8%) | 32(5.9%) | 26(4.2%) | 40(10.2%) | 26(4.9%) | 33(5.5%) | 0.005° |